The effects of paravertebral blockade usage on pulmonary complications, atrial fibrillation and length of hospital stay following thoracoscopic lung cancer surgery

医学 不利影响 麻醉 心房颤动 肺癌 倾向得分匹配 心胸外科 优势比 回顾性队列研究 外科 内科学
作者
Chaoyang Tong,Jijian Zheng,Jingxiang Wu
出处
期刊:Journal of Clinical Anesthesia [Elsevier BV]
卷期号:79: 110770-110770 被引量:8
标识
DOI:10.1016/j.jclinane.2022.110770
摘要

Although combined thoracic paravertebral blockade (TPVB)-general anesthesia (GA) could improve pain control compared to GA alone after thoracoscopic lung cancer surgery, it has not been established whether this improvement in pain control could reduce associated adverse outcomes. Thus, this study aimed to explore the association between TPVB usage and adverse outcomes after thoracoscopic lung cancer surgery. Retrospective cohort study from a prospective database. A high-volume thoracic center in China. 13966 consecutive patients who received thoracoscopic lung cancer surgery from January 2016 to December 2018 in Shanghai Chest Hospital were enrolled. With a 1:1 propensity score matching (PSM) analysis, adverse outcomes between GA alone and GA-TPVB were investigated. Multivariate and multiple linear regression analysis were used to identify factors and calculate odds radio (OR) for adverse outcomes. The rate of TPVB usage was 14.8% (2070 out of 13,966). TPVB combined with GA was associated with lower rates of postoperative pulmonary complications (PPCs) (30.4% vs 33.5%, P = 0.005) and postoperative atrial fibrillation (POAF) (2.1% vs 2.9%, P = 0.041), and shorter length of hospital stay (LOS) (Median [IQR]; 5[4-5] vs 5[4-6]) days, P < 0.001) compared to GA alone. After a 1:1 PSM analysis, we investigated adverse outcomes in 2640 (1320 pairs) patients with or without TPVB usage, and this association remained existed, namely, the rates of PPCs (29.8% vs 34.2%, P = 0.014) and POAF (2.2% vs 3.6%, P = 0.028) were lower and LOS was shorter (5[4-5] vs 5[4-6] days, P < 0.001) in the GA-TPVB group. In multivariate analysis, the combination of GA plus TPVB was independent predictor for PPCs (OR = 0.879, 95%CI, 0.793–0.974, P = 0.014) and POAF (OR = 0.714, 95%CI, 0.516–0.988, P = 0.042), respectively. However, in multiple linear analysis, lower rates of PPCs and POAF associated with TPVB usage, rather than TPVB usage, were responsible for the reduced LOS. The usage of TPVB may be a feasible and adjustable approach to reduce the rates of PPCs and POAF and associated LOS in thoracoscopic lung cancer surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
任性的白玉完成签到 ,获得积分10
刚刚
youwenjing11发布了新的文献求助10
1秒前
山谷完成签到 ,获得积分10
1秒前
钱宇成发布了新的文献求助10
2秒前
科研通AI2S应助感动黄豆采纳,获得10
6秒前
10秒前
11秒前
14秒前
Fengliguantou发布了新的文献求助10
14秒前
猪猪hero发布了新的文献求助10
16秒前
Winner发布了新的文献求助10
18秒前
隐形曼青应助科研通管家采纳,获得10
18秒前
领导范儿应助科研通管家采纳,获得10
18秒前
Lucas应助科研通管家采纳,获得30
19秒前
19秒前
圆锥香蕉应助科研通管家采纳,获得20
19秒前
科研通AI2S应助科研通管家采纳,获得10
19秒前
科研通AI2S应助科研通管家采纳,获得10
19秒前
科目三应助科研通管家采纳,获得10
19秒前
充电宝应助科研通管家采纳,获得10
19秒前
脑洞疼应助科研通管家采纳,获得10
19秒前
科研通AI5应助科研通管家采纳,获得10
19秒前
852应助科研通管家采纳,获得10
19秒前
科研通AI2S应助科研通管家采纳,获得10
19秒前
科研通AI2S应助科研通管家采纳,获得10
19秒前
情怀应助科研通管家采纳,获得10
20秒前
20秒前
感动黄豆发布了新的文献求助10
20秒前
23秒前
搞怪冷风完成签到,获得积分10
24秒前
lucky完成签到,获得积分10
24秒前
量子星尘发布了新的文献求助10
25秒前
27秒前
科目三应助战斗暴龙兽采纳,获得10
31秒前
31秒前
31秒前
32秒前
32秒前
35秒前
故意的靳发布了新的文献求助50
36秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989115
求助须知:如何正确求助?哪些是违规求助? 3531367
关于积分的说明 11253688
捐赠科研通 3269986
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882078
科研通“疑难数据库(出版商)”最低求助积分说明 809105